Target intelligence / Profile preview

Tumor cell membrane lipid raft (null)

Target
null
Molecular classification
Other (membrane microdomain, cholesterol/sphingolipid-rich lipid platform)
01

Overview

Tumor cell membrane lipid rafts are small (10–200 nm), heterogeneous, cholesterol- and sphingolipid-enriched microdomains in the plasma membrane that serve as organizing centers for signaling, adhesion, and trafficking proteins in tumor cells[3][5][6]. They facilitate compartmentalization of receptors and signaling molecules, modulate processes such as migration, apoptosis, and drug resistance, and are often more abundant or altered in cancer cells compared to normal cells[1][3][5][6]. Disruption or targeting of lipid raft integrity can interfere with multiple pathways involved in tumor progression and is an active area of therapeutic research[1][2][6][8].

Other names
Lipid raftMembrane raftMembrane microdomainCholesterol-rich microdomain
02

Mechanism of action

Disruption of raft integrity by depleting cholesterol leads to impaired receptor signaling and promotes apoptosis (e.g., with statins, methyl-β-cyclodextrin); Promoting clustering or recruitment of death receptors in rafts facilitates apoptotic signaling (e.g., with perifosine, edelfosine); Modulation of raft-associated signaling pathways (e.g., PI3K/AKT, IGF, Fas/CD95, Wnt/β-catenin)

03

Biological functions

Signal transductionCell adhesionCell migration/invasionCell survivalApoptosis (programmed cell death)Cell differentiation and stemnessDrug resistance
04

Disease associations

CancerPossibly other diseases involving membrane signaling, but primary literature focus is cancer
05

Safety considerations

Targeting lipid rafts may disrupt essential signaling in normal cellsPotential off-target effects on immune cells and non-tumor tissuesBroad impact on membrane and organelle function could yield unpredictable toxicity
06

Interacting drugs

Statins (cholesterol-lowering drugs, e.g., simvastatin, lovastatin)

5 more in the full profile.

07

Biomarkers

Caveolin-1 (a raft marker protein, also marker of caveolae type of rafts)Flotillin-1/2 (raft marker proteins, associated with poor prognosis in cancer)Increased membrane cholesterol

Beyond the preview

Go deeper on Tumor cell membrane lipid raft (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor cell membrane lipid raft (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call